<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-vaccines-08-00224">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Trouillet-Assant</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Viel</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gaymard</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Pons</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Richard</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Perret</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Villard</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Brengel-Pesce</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Lina</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Mezidi</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Type I IFN immunoprofiling in COVID-19 patients</article-title>
  <source>J. Allergy Clin. Immunol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/j.jaci.2020.04.029</pub-id>
  <?supplied-pmid 32360285?>
  <pub-id pub-id-type="pmid">32360285</pub-id>
 </element-citation>
</ref>
